The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The Business Research Company’s anticoagulants market report forecasts the anticoagulants market size to grow to $66.32 Billion by 2027, with a CAGR (compound annual growth rate) of more than 10%.

Learn More On The Anticoagulants Market Report 2023 – https://www.thebusinessresearchcompany.com/report/anticoagulant-global-market-report

Anticoagulants Market Size Forecast
The global anticoagulants market is expected to grow from $40.63 billion in 2022 to $44.81 billion in 2023 at a compound annual growth rate (CAGR) of 10.3%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The anticoagulants market size is expected to grow to $66.32 billion in 2027 at a CAGR of 10.3%.

North America held the largest anticoagulants market share.

Key Anticoagulants Market Driver ­– Increase In Cardiovascular Diseases
According to the World Health Organization report in 2021, cardiovascular diseases claimed the lives of 17.9 million individuals worldwide, accounting for 32% of all deaths. Heart attacks and strokes were responsible for 85% of these deaths. Therefore, the increasing cardiovascular diseases drive the growth of the anticoagulants market.

Request for A Sample Of The Global Anticoagulants Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=5230&type=smp

Key Anticoagulants Market Trend – Ongoing Clinical Trials Of Anticoagulant Treatments For COVID-19
Major companies operating in the anticoagulants sector are concentrating on establishing clinical trials of anticoagulant medications to lower the risk of COVID-19-related blood clotting in adults. For instance, in March 2021, The National Institutes of Health (NIH) in the USA started the final of three Phase III clinical trials of blood thinners (anticoagulants) to prohibit life-threatening blood clots in elderly people with COVID-19. The ACTIV-4 trials will help to resolve concerns about the use of anticoagulants also known as antithrombotics in the treatment of COVID-19.

Anticoagulants Market Segment
1) By Drug Class: Factor Xa Inhibitor, Heparin And LMWH, Vitamin K Antagonist, Other Drug Classes
2) By Route Of Administration: Oral Anticoagulant, Injectable Anticoagulant
3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy
4) By Application: Venous Thromboembolism, Atrial Fibrillation Or Flutter, Coronary Artery Disease, Other Applications
5) By End User: Hospitals, Homecare, Specialty Centers, Other End-Users

Anticoagulants Market Major Players and Strategies
Major players in the anticoagulants market are GlaxoSmithKline plc., Pfizer Inc., Sanofi, Mylan, Bayer AG, Boehringer Ingelheim International GmbH, Daiichi Sankyo, Alexion Pharmaceuticals Inc., Otsuka, Leo Pharma, Eisai Co. Ltd., and Amphastar Pharmaceutica.

In July 2020, Alexion Pharmaceuticals Inc., a US-based biopharmaceutical company acquired Portola Pharmaceuticals Inc., for an amount of $1.41 billion. Through this acquisition Andexxa, a factor Xa inhibitor reversal agent marketed as Ondexxya in Europe has been added to Alexion Pharmaceuticals Inc.,’s commercial portfolio. Portola Pharmaceuticals Inc., is a US-based clinical-stage biopharmaceutical company with an anticoagulant Bevyxxa under its portfolio.

The Anticoagulants Global Market Report 2023 covers regional data on anticoagulants market size, anticoagulants market trends and drivers, opportunities, strategies, and anticoagulants market competitor analysis. The countries covered in the anticoagulants market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

Anticoagulants refer to a drug used to prevent and treat blood clots in the heart and blood arteries. called a blood thinner as well. It is utilised to slow down the body’s clotting process. These are blood thinners, but they do not thin the blood, instead, they avoid or minimize clots or thrombi.

View More Reports Related To The Anticoagulants Market –
Dialysis Devices And Equipment Global Market Report 2023
AntiHypertensive Drugs Global Market Report 2023
Antivirals Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on: